Environmental Xenobiotic Disruption of Lysosomal Membrane Integrity: Mechanisms and Consequences for Human Health

1. Introduction

Lysosomes are organelles that contain over 60 hydrolases capable of digesting proteins, nucleic acids, carbohydrates, and lipids. These enzymes are active in an acidic milieu, pH 4.5 - 5.0. This acidic environment is preserved by the activity of the vacuolar ATPase (v-ATPase) and counter-ion transport systems, including Na+/K+ leakage and Cl- import. [1,2].

Lysosomal digestion must take place within the lysosomal lumen to avoid degradation of the entire cell. As a result, the lysosomal membrane has a dualism of function. It provides structural support against mechanical stress and isolation of the lysosomal hydrolases and sequestered xenobiotics from the cytosol. Subtle alterations of this barrier can disrupt luminal pH, impair autophagic flux, and trigger signaling pathways resulting in adaptive repair or cell death [3].

Human exposure to lysosomotropic xenobiotics is neither rare nor confined to occupational settings. Population biomonitoring detects PFAS in nearly all serum samples tested, with US adult geometric mean concentrations of 9.72 ng/mL for PFOS and 3.07 ng/mL for PFOA [4], prompting the US Environmental Protection Agency (EPA) to set enforceable drinking-water limits of 4.0 parts per trillion for PFOA and PFOS and 10 parts per trillion for PFHxS, PFNA, and HFPO-DA in 2024 [5]. Redox-active metals face similarly stringent limits, with an EPA drinking-water maximum contaminant level of 0.005 mg/L for cadmium and an action level of 0.015 mg/L for lead [6], reflecting long-standing concern over their capacity to accumulate in tissue. Airborne particulate exposure is regulated even more broadly: the EPA tightened its annual fine particulate matter (PM2.5) standard from 12.0 to 9.0 μg/m3 in 2024 in direct response to evidence of harm at previously permitted levels [7]. These regulatory thresholds are set primarily from epidemiological and whole-organism toxicity data; the subcellular, lysosome-centered mechanisms reviewed here provide a complementary, mechanistic basis for understanding why exposures below acute toxicity thresholds can nonetheless produce cumulative tissue injury.

Lysosomes have been shown to be uniquely vulnerable to a variety of mechanical, oxidative, and metabolic stressors. Several reports demonstrate that environmental toxins, cationic amphiphilic drugs, heavy metals, nanoparticles, and organic pollutants preferentially accumulate within lysosomes. These agents can induce lysosomal membrane permeabilization (LMP), characterized by pore formation and cytosolic leakage, or lysosomal membrane rupture (LMR), defined by bilayer failure and uncontrolled enzyme release [3,8]. LMP and LMR are mechanistically and functionally distinct. Partial and transient LMP activates the intrinsic apoptotic pathway initiated by cathepsin release, whereas extensive membrane disruption results in necrosis, inflammation, or ferroptosis.[8,9].

Therefore, the severity and speed of lysosomal membrane damage ultimately decide the cell's fate. Lysosomes are the primary sites of sequestration for xenobiotics. The major routes by which xenobiotics accumulate within these organelles and initiate intralysosomal stress are summarized in Figure 1.

This makes lysosomes attractive targets for developing novel therapeutic strategies that exploit lysosomal vulnerabilities, particularly in cancer cells that expanded lysosomal compartments for proliferation and drug resistance [10]. Lysosomal damage does not always result in cell death. Cells possess membrane repair and regeneration networks that restore lysosomal integrity following injury. These pathways include ESCRT-III-mediated membrane sealing, lipid reinforcement, and organelle regeneration [11]. When these protective mechanisms fail, lysosomes are transformed from stress responders to inducers of cell death. This review examines how environmental xenobiotics disrupt lysosomal membranes, the processes that counteract this damage, and the consequences when repair fails.

2. Classes of Lysosomotropic Xenobiotics

Lysosomes are preferentially targeted by chemicals for two reasons, namely thermodynamics and compartment biology. The intralysosomal pH gradient drives protonation and trapping of lipophilic, weak bases that diffuse across the lysosomal membrane in its neutral form. The resulting ion-trapped species, which cannot freely exit, can cause concentrations within the lysosomal lumen to exceed cytosolic levels by two to three times [12]. Compounding this chemical sequestration is the lysosome’s role as the terminal destination for autophagic substances, including metalloprotein complexes and lipid droplets, which delivers additional redox-reactive substrates directly into the lumen.

Lysosomotropic xenobiotics fall into three operationally useful categories: weak-base cationic amphiphiles, redox-active and non-redox metals, and insoluble particulates. They differ considerably in structure but share the capacity to exploit lysosomal chemistry. Cationic amphiphilic drugs accumulate through classical ion trapping and disrupt lipid packing; redox-active metals, such as iron and copper, drive Fenton-type hydroxyl radical generation within the acidic lumen; and particulates impose sustained mechanical and oxidative stress that lysosomal hydrolases cannot resolve.

The lysosomotropic behavior of cationic amphiphilic drugs (CADs) is primarily based on their structure. CADs carry both a hydrophobic domain and a weakly basic amine, which means that at physiological pH they exist in their uncharged form. Passive diffusion carries them across the plasma membrane and into the lysosomal lumen, where the sharply acidic environment protonates the amine group. The charged species can no longer move out of the lysosome via passive transport, and so the drug accumulates. This is ion trapping, resulting in intralysosomal CAD concentrations that can reach levels two to three orders of magnitude above the cytosol [13].

Paradoxically, the lysosome’s initial success in isolating these potentially toxic compounds from cytosolic targets becomes its downfall. This protective sequestration is ultimately unsustainable; CADs progressively accumulate, they drive up osmotic pressure and place the lysosomal membrane under severe mechanical tension [14]. Consequently, the luminal pH destabilizes, autophagic flux fails, and the organelle transforms from a vital detoxification site into a cellular liability.

Cancer cells utilize similar mechanisms to evade therapy. By expanding lysosomal volume and upregulating transporters such as LAPTM4B and P-glycoprotein, malignant cells divert chemotherapeutic CADs, such as doxorubicin, sunitinib, tamoxifen, away from their intended nuclear or cytosolic targets. The drug reaches the cell but never reaches its mark, and the cell survives a dose that should have been lethal [14,15].

2.1. Weak-Base Sequestration and Ion Trapping

A large fraction of lysosomotropic agents are cationic amphiphilic drugs (CADs), characterized by hydrophobic regions and weakly basic amine groups. These compounds readily diffuse across cellular membranes in their unprotonated form and preferentially accumulate within acidic compartments such as lysosomes. Upon entry into the lysosomal lumen, protonation renders them membrane-impermeable, a phenomenon known as ion trapping [13]. As a result, CAD concentrations within lysosomes can exceed cytosolic concentrations by several orders of magnitude.

Although this sequestration may initially function as a protective detoxification mechanism by isolating xenobiotics from sensitive cytosolic targets, sustained accumulation induces osmotic swelling, elevation of intralysosomal pressure, destabilization of luminal pH, and progressive membrane tension [14]. Over time, these biophysical stresses promote lysosomal membrane permeabilization and impair autophagic flux. In cancer cells, ion trapping contributes directly to multidrug resistance by diverting chemotherapeutic agents away from their intended targets, such as nuclear DNA or cytosolic kinases. Expansion of the lysosomal compartment and upregulation of lysosomal transporters further reinforce this compartmentalized resistance mechanism, enabling malignant cells to survive otherwise lethal drug exposures [14,15].

2.2. Metal Sequestration and Redox Cycling

Lysosomes also serve as central hubs for intracellular metal handling, as they degrade metalloproteins, metal-binding complexes, and iron-storage proteins delivered through autophagy. This role places lysosomes at the intersection of metal detoxification and redox biology, rendering them especially vulnerable to metal-induced oxidative injury. Table 1 shows several metals that are sequestered in lysosomes.

2.2.1. Iron

Lysosomal iron accumulation depends heavily on ferritinophagy, a selective autophagic route driven by the cargo receptor NCOA4. Once inside the lysosomal lumen, Fe3+ is reduced to Fe2+ by metalloreductases, creating an unstable, highly reactive lysosomal iron pool. This localized Fe2+ acts as a powerful Fenton catalyst; it readily splits hydrogen peroxide to yield hydroxyl radicals, which are among the most destructive reactive oxygen species (ROS) known in biology [18]. These aggressive radicals target polyunsaturated fatty acid side chains directly within the lysosomal membrane. The resulting lipid peroxidation chain reaction creates oxidative pores and destabilizes the bilayer, ultimately causing lysosomal membrane permeabilization (LMP) and triggering both apoptotic and ferroptotic pathways. Compartmentalization is what makes this process so lethal. Rather than scattered toxicity, the lysosome provides a perfect environment: it aggregates labile iron via ferritinophagy, maintains the acidic pH necessary to stabilize Fe2+, and faces a constant barrage of oxidative inputs. These three variables actively synergize, turning the organelle into the primary subcellular site where the precise chemical thresholds for Fenton-driven membrane rupture are achieved [15,18]. In humans, iron overload of this kind is most often dietary or supplement-related, with additional relevance in hereditary hemochromatosis-adjacent physiology [6].

2.2.2. Copper

Copper overload does more than just generate localized ROS; it actively damages lysosomal structure. Excess copper destabilizes endoplasmic reticulum (ER)–lysosome contact sites, interfering with the lipid transfer and sterol homeostasis required for routine membrane repair. At the molecular level, copper impairs vesicular trafficking and blocks ER-to-lysosome lipid delivery by compromising adaptor proteins like LAPTM4B [17]. Stripped of these structural lipids, lysosomes lose their ability to heal oxidative lesions, making them unstable and prone to catastrophic rupture. Because this copper-induced lysosomal breakdown occurs in both mammalian and non-mammalian models, it represents a fundamentally conserved cytotoxic pathway [16]. Human copper exposure is predominantly occupational or arises from corroded plumbing; the EPA action level for lead-associated corrosion, a common co-contaminant with copper in plumbing, is 0.015 mg/L [6].

2.2.3. Cadmium

Rather than relying on Fenton chemistry like redox-active metals, cadmium compromises lysosomes through non-redox mechanisms. It gains entry bound to metallothioneins or within endocytosed protein aggregates, where it proceeds to disrupt protein folding, disable local antioxidant defenses, and incapacitate autophagic flux. This intra-lysosomal buildup soon culminates in LMP, spilling destructive cathepsins into the cytoplasm and driving apoptosis-like cell death [23]. Because hepatic and phagocytic lines are heavily reliant on these trafficking pathways, they exhibit a severe, tissue-specific vulnerability to this form of cadmium toxicity. In humans, cadmium accumulates from tobacco smoke and contaminated shellfish or leafy vegetables; the EPA drinking-water maximum contaminant level for cadmium is 0.005 mg/L [6].

2.3. Nanoparticles and Environmental Particulates

Both engineered nanoparticles and airborne fine particulate matter act as potent lysosomotropic stressors. After entering cells through diverse endocytic routes, such as phagocytosis, macropinocytosis, or clathrin-mediated pathways, these non-biodegradable particulates accumulate inside lysosomes, opposing enzymatic clearance. Their toxic potential is based on physical properties like size, shape, crystallinity, and surface charge. Sequestration leads to direct organelle failure via several mechanisms: mechanical membrane damage, localized ROS surges, altered luminal acidity, and disrupted autophagy. This toxicity manifests across varied particulate types; carbon quantum dots disturb cellular bioenergetics and alter basic lysosomal physiology [24], while vehicle emissions and urban air pollutants alter luminal pH to compromise hydrolase function and drive LMP [25]. Chronic exposure to these particles stalls autophagic clearance and ignites downstream inflammatory cascades, marking the lysosome as the primary casualty of nanoparticle toxicity [26].

3. PFAS Accumulation and Lysosomal Membrane Stress

Beyond standard xenobiotic threats, per- and polyfluoroalkyl substances (PFAS) present a unique danger to lysosomes. Instead of behaving like typical weak-base compounds, PFAS leverage their highly hydrophobic, fluorinated carbon backbones to embed directly into lipid membranes. This biophysical profile forces the progressive entrapment of PFAS within endolysosomal pathways [27]. Lacking an efficient clearance mechanism, the organelle suffers long-term retention that amplifies cellular distress, ultimately altering membrane architecture, locking down autophagic flux, and sensitizing the cell to secondary metabolic stresses [28].

3.1. Chain-Length Dependency of PFAS Toxicity

Fluorocarbon chain length acts as a primary gatekeeper for PFAS-induced lysotoxicity. Testing across hepatic models shows a clear trend: the longer the perfluorinated chain, the greater its lysosomal retention and subsequent cytotoxic impact. Long-chain variants exhibit a heightened affinity for lipid bilayers, anchoring themselves deeply within endolysosomal compartments [29]. This physical entrapment triggers heavy cellular pushback; for instance, HepaRG and HepG2 cells respond to long-chain PFAS by upregulating amino acid and xenobiotic transporters as part of a broader compensatory metabolic survival strategy [30,31]. This burden drops off significantly with shorter-chain analogs, which are cleared rapidly and leave lysosomal function largely intact [32].

3.2. Sequestration and Lipid Binding Within Lysosomes

Inside the cell, internalized PFAS show sharp co-localization with lysosomal markers. They cause direct structural damage by driving their fluorinated tails straight into the membrane, disrupting the bilayer architecture and crowding out resident phospholipids [33]. While classic weak-base compounds clear out relatively fast, PFAS display remarkably sluggish kinetics. The result is a state of perpetual membrane stress that eventually paralyzes autophagic degradation [29]. This ongoing sequestration effectively primes the organelle for failure, dramatically lowering the threshold required for oxidative stress to trigger LMP [34].

3.3. Oxidative Stress and Lysosome-Centered Toxicity

PFAS exposure has been linked to increased intracellular ROS generation, which exacerbates lysosomal vulnerability. Subcellular imaging studies demonstrate that PFAS-induced oxidative stress concentrates within lysosomal regions, where redox-active metal pools favor lipid peroxidation reactions [35,36]. ROS initiate peroxidation of polyunsaturated fatty acids in the limiting membrane, compromising lipid packing density and generating nanoscale oxidative pores [37,38]. As oxidative injury accumulates, cells transition from adaptive stress responses toward regulated cell death pathways [39].

4. Mechanisms Governing Lysosomal Membrane Repair

To survive oxidative, mechanical, and chemical challenges, lysosomes utilize an active, highly regulated array of repair mechanisms. Cells orchestrate these defenses in a hierarchical manner, deploying distinct pathways depending on the size and timeline of the injury—moving from the rapid closure of nanoscale punctures to total organelle regeneration.

4.1. ESCRT-III-Driven Sealing of Membrane Lesions

The cell counters minor lysosomal breaches using the Endosomal Sorting Complex Required for Transport (ESCRT) complex as its primary rapid responder [40]. Micro-disruptions trigger a localized flash of Ca2+ efflux, which instantly flags the damage site and docks the adaptor proteins ALIX and TSG101 [41]. These adaptors recruit ESCRT-III core components, driving the polymerization of subunits like CHMP4B into helical, curved filaments that draw the edges of nanoscale pores together until they seal [42]. To wrap up the repair sequence, the AAA-ATPase VPS4 drives the energy-dependent disassembly and recycling of these ESCRT-III complexes [43].

4.2. ER–Lysosome Contact Sites and Lipid-Mediated Membrane Reinforcement

Severe membrane breaches that overwhelm ESCRT-III capacity force the cell to engage a secondary, structural defense pathway operating at ER–lysosome contact zones [44]. These specialized junctions provide a highway for direct lipid transfer, allowing the ER to directly shore up the compromised lysosomal membrane. Mechanistically, ORP1L drives this process by moving cholesterol directly into the lysosomal bilayer to correct damage-induced lipid imbalances [45,46]. This rapid influx of lipids stabilizes the structural integrity of the broken membrane, creating a barrier that curtails cytosolic cathepsin leakage [47,48]. Crucially, impairing this ER-mediated lipid delivery strips the organelle of its resilience, sensitizing lysosomes to chemical injury and ensuring progression toward unmitigated rupture [49,50].

4.3. Lysosomal Regeneration and Organelle Renewal Pathways

Irreparable structural damage forces the cell to abandon patch-repair and instead trigger wholesale organelle regeneration. A major arm of this recovery is autophagic lysosomal reformation (ALR), which is controlled upstream by the Rab7 GTPase-activating protein TBC1D15 [51,52]. Under conditions of energetic stress, however, the cell relies on a distinct TECPR1-mediated pathway that pulls double duty by sprouting new membrane tubules directly out of the damaged lysosomal remnants [53]. Ultimately, the collapse or exhaustion of these homeostatic backup systems defines a terminal cellular threshold—the precise point where the broken lysosomes cease attempting self-repair and actively spark regulated cell death [54].

5. Downstream Execution Pathways of Lysosomal Injury

The structural kinetics of lysosomal injury act as the primary determinant of downstream cellular fate. The specific threshold of membrane permeabilization, coupled with the rate of luminal leakage, actively shapes the cellular microenvironment to favor either apoptotic, ferroptotic, necroptotic, or distinctly inflammatory modes of regulated cell death.

5.1. Cathepsin-Mediated Apoptosis

Partial and regulated LMP permits controlled release of cathepsins B and D into the cytosol [55]. One of the central mechanisms involves cathepsin-mediated cleavage of BID into truncated BID (tBID), which promotes mitochondrial outer membrane permeabilization (MOMP) and caspase activation [56]. Cathepsin B was shown to be responsible for initiating the mitochondrial apoptotic pathway and TNF-induced apoptosis in hepatocytes [57]. Cathepsins B and D, which are also active at neutral pH, trigger caspase-dependent and caspase-independent cell death both in physiological and pathological conditions [58,59] . Cathepsin D activates caspase-8 in mature neutrophils, resulting in Bax cleavage, activation of caspase-3, and apoptosis [60].

5.2. Lysosomal Iron Sequestration in Ferroptotic Signaling

Lysosomes acquire their iron burden through NCOA4-mediated ferritinophagy, a pathway that concentrates Fe2+ within the organelle's acidic interior. Under oxidative conditions, this localized iron surplus acts as a volatile substrate for Fenton chemistry, generating highly destructive hydroxyl radicals that systematically strip the lysosomal membrane via lipid peroxidation [19,20]. This progressive structural breakdown culminates in LMP. Once breached, the lysosome leaks Fe2+and lipid peroxides into the cytoplasm, drastically amplifying the cellular ferroptotic program [21]. This critical dependence is highlighted by pharmacological interventions: lowering lysosomal iron accumulation breaks this circuit, actively protecting cells against ferroptosis [61,62].

5.3. Necroptosis and Endolysosomal Collapse

Necroptosis directly impacts lysosomal stability when the executioner protein phospho-MLKL (pMLKL) docks onto membrane-bound phosphatidylinositol phosphates (PIPs) [63]. This interaction induces rapid, early LMP, neutralizing the organelle's proton gradient and driving structural decay. This breach allows cathepsins B and D to escape into the cytosol, transforming them from localized hydrolases into active drivers of cell death that accelerate necrosome assembly [64]. Mechanistically, these escaped cathepsins act as broad-spectrum proteases, clearing away the inhibitory regulators that would otherwise keep the necroptotic machinery in check [65]. The sudden, high-concentration flooding of the cytosol by these enzymes inflicts irreversible damage, stripping the cell of any capacity for homeostatic repair and locking in the death program.

6. Lysosomal Sequestration and Drug Resistance: Translational Relevance

The same sequestration mechanisms that concentrate environmental xenobiotics within lysosomes also trap a range of lipophilic, weak-base chemotherapeutics, including anthracyclines such as doxorubicin, tyrosine kinase inhibitors such as sunitinib, and lysosomotropic agents such as siramesine and triptolide [66,67,68,69,70,71,72,73,74,75]. Protonation and confinement within the acidic lumen sequesters these drugs away from their nuclear or mitochondrial targets, and tumor cells frequently upregulate transporters such as P-glycoprotein and LAPTM4B to reinforce this trapping, producing a clinically significant form of multidrug resistance [69,70,71]. Because hypertrophied tumor lysosomes are simultaneously more susceptible to LMP, this same fragility is being explored therapeutically, for example through triptolide-induced LMP in caspase-3-deficient breast cancer cells and combinatorial regimens pairing lysosomal destabilizers with BH3 mimetics [76,77,78,79,80,81,82,83,84,85,86]. A full treatment of lysosome-targeted oncology therapeutics is beyond the environmental-health focus of this review; we summarize it briefly here because it illustrates the dual, context-dependent significance of the same membrane vulnerability discussed throughout.

7. Nanoparticles and Environmental Particulates

Lysosomal networks are increasingly challenged by engineered nanoparticles and environmental particulates, which act as robust lysosomotropic stressors. Once compartmentalized, these xenobiotics exert continuous chemical and mechanical pressure alongside oxidative insult, often surpassing the cell's homeostatic defense mechanisms. This chronic overload frequently induces catastrophic lysosomal membrane failure, an event heavily linked to cascading oxidative damage, inflammatory signaling, secondary DNA lesions, and alternative pathways of programmed or unprogrammed cell death [87,88,89,90].

7.1. Cell-Type-Specific Lysosomal Vulnerability

Organelle-level responses to particulate stress vary significantly across different tissue types. While hepatocytes successfully counteract moderate nanoparticle accumulation by mobilizing TFEB–dependent autophagic pathways and expanding their lysosomal networks [91,92], immune cells do not fare as well. Professional phagocytes internalize these materials at far greater magnitudes, a process that disrupts luminal pH regulation and precipitates early-onset LMP [93].

7.2. Environmental Particulates and Lysosomal Dysfunction

Particulate matter from ambient pollution, particularly automotive exhaust, exhibits long-term persistence within lysosomes where it interferes with normal acidification. In respiratory epithelial cells, this particulate accumulation has been shown to elevate lysosomal pH and compromise structural integrity, thereby driving the onset of progressive LMP [94,95]. These subcellular findings are consistent with the trajectory of ambient air quality regulation: the EPA's 2024 downward revision of the annual PM2.5 standard from 12.0 to 9.0 μg/m3 reflects epidemiological evidence of health effects at concentrations previously considered acceptable, a pattern the lysosomal injury mechanisms above may help explain at the cellular level [7].

7.3. Sentinel Organisms and Lysosome-Related Organelles

To evaluate the sublethal effects of environmental pollutants, researchers frequently utilize non-mammalian sentinel models like Caenorhabditis elegans, which feature specialized lysosome-related organelles (LROs) [22,96,97]. Environmental toxins compromise these systems by altering LRO-mediated signaling and provoking immune responses. Notably, exposure to Bt-Cry1Ab in Spodoptera litura induces distinct morphological and ultrastructural abnormalities within the lysosomal compartment [98].

8. Adaptive Lysosomal Stress Responses

When subjected to persistent or low-grade stress, cellular systems mobilize a diverse array of protective feedback loops. These survival strategies encompass widespread changes in gene expression, targeted autophagic degradation, and alterations in membrane composition, which collectively preserve the architectural stability of the broader lysosomal network.

8.1. TFEB-Mediated Lysosomal Biogenesis and Functional Recovery

Transcription Factor EB (TFEB) acts as the principal controller of lysosomal biogenesis. When lysosomes experience functional stress, mTORC1 activity is inhibited, prompting TFEB dephosphorylation and its subsequent migration into the nucleus [99,100]. Once localized there, it activates the CLEAR gene network to stimulate the expression of various lysosomal hydrolases and membrane scaffolding proteins [101,102]. This TFEB-mediated expansion of the lysosomal network generally provides vital cytoprotection against cell death pathways [103]. Nonetheless, recent literature highlights a dual role for this system, demonstrating that certain cellular contexts can shift TFEB-dependent lysosomal remodeling toward a pro-apoptotic outcome [104].

8.2. Lysophagy: Selective Clearance of Damaged Lysosomes

Cells rely on lysophagy as a quality-control mechanism to eliminate severely damaged lysosomes that are beyond repair. The initiation of this pathway depends on the exposure of intraluminal glycan motifs to the cytosol, which prompts the immediate binding of galectins, particularly galectin-3 [105]. Once bound, these galectins serve as a beacon for autophagy receptors, facilitating the structural linkage of the damaged lysosome to the emerging autophagosomal membrane [106,107].

8.3. Microautophagy and Membrane Remodeling

Through microautophagy, lysosomes can directly invaginate their own limiting membranes to selectively isolate and degrade oxidized lipids or compromised membrane microdomains. This internal maintenance pathway relies heavily on phosphoinositide-mediated signaling governed by PIKfyve [108]. Additionally, components of the ESCRT machinery are recruited to physically shape and sever these membrane topologies during microautophagic internalization [109,110].

9. Therapeutic and Translational Implications

Contemporary research has recharacterized the lysosome from a simple degradative vacuole into a pivotal determinant of cell fate and drug sensitivity. Harnessing this organelle's structural vulnerabilities, specifically via the fine-tuning of lysosomal membrane permeability, presents an expanding, clinically actionable framework for counteracting both treatment-resistant malignancies and xenobiotic-induced toxicities.

9.1. Note on Oncology Applications

The same lysosomal fragility that underlies environmental toxicant injury is, in disease contexts such as drug-resistant cancer, deliberately exploited: lysosomotropic agents and aptamer-functionalized delivery platforms can trigger LMP-driven cell death in neoplastic cells, particularly when combined with BH3 mimetics that heighten mitochondrial priming [82,83,84,85,86]. This oncology application is noted briefly for context; it is not the focus of the present review.

9.2. Reinforcing Lysosomal Integrity in Degenerative Disease and Toxicology

While oncological therapies seek to compromise the lysosome, managing neurodegeneration and environmental toxicities requires strategies that reinforce its structural stability. Various pharmacological candidates engineered for this purpose are outlined in Table 2. Among these, agents that upregulate heat shock protein 70 (HSP70) exert strong cytoprotective effects by mitigating the lysosomal degradation typically brought on by intracellular oxidative stress [111,112]. Furthermore, facilitating the recruitment and kinetic efficiency of the ESCRT-III complex represents a promising therapeutic avenue to reinforce the limiting membrane against mechanical damage [113].

9.3. Emerging Biological Models and Imaging Technologies

Characterizing sublethal lysosomal injury under xenobiotic stress has been significantly accelerated by modern biological models and optical innovations. While non-mammalian sentinel organisms featuring LROs serve as highly sensitive platforms for screening systemic environmental toxicities [22,96,97,98], stimulated Raman scattering (SRS) microscopy provides a microscopic window into the organelle itself. This imaging modality allows investigators to monitor lipid peroxidation and real-time membrane remodeling within live-cell lysosomes without the artifacts often introduced by chemical labels [114,115].

9.4. Implications for Biomarkers and Environmental Risk Assessment

The mechanisms reviewed here point toward a practical translation from bench to environmental health practice. Because sublethal LMP precedes overt cytotoxicity, molecular readouts of intralysosomal stress, such as galectin puncta formation, TFEB nuclear translocation, or cathepsin leakage into the cytosol, are candidate biomarkers for detecting subclinical xenobiotic injury before it manifests as tissue-level disease [99,105]. Current regulatory exposure limits for PFAS, heavy metals, and particulate matter are derived largely from epidemiological endpoints and whole-organism toxicity studies [4,5,6,7]; incorporating lysosomal stress and repair-capacity markers into biomonitoring could offer a mechanistic complement to these limits, particularly for cumulative, low-dose exposures that fall below acute toxicity thresholds but may still exceed the repair capacity of chronically stressed tissue. Non-mammalian sentinel models and vibrational imaging modalities discussed above are well suited to generating the dose-response data such biomarker-informed thresholds would require [22,96,97,98,114,115].

10. Conclusions

Ultimately, the lysosomal limiting membrane functions as a critical regulatory checkpoint that determines cell survival or demise under chemical challenge. A diverse array of xenobiotics manipulate the unique intraluminal environment of this organelle, driving localized damage via mechanisms such as lysosomal ion trapping, metal-catalyzed Fenton reactions, and oxidative lipid peroxidation [116,117,118]. Crucially, lysosomal injury does not automatically trigger an irreversible death cascade. Instead, cells mobilize a sophisticated, hierarchical network of defense mechanisms, including immediate ESCRT-mediated membrane patching, endoplasmic reticulum-driven lipid donation, and TFEB-dependent organelle biogenesis, to restore cellular homeostasis [119]. The kinetic interplay between the rate of membrane damage and the efficiency of these repair loops determines whether lysosomal membrane permeabilization (LMP) remains a reversible stress state or escalates into catastrophic rupture and subsequent programmed cell death, a distinction with direct bearing on how chronic, low-dose environmental exposures translate into tissue-level disease over time. For environmental health practice, this framework suggests that lysosomal stress and repair markers merit consideration as candidate biomarkers of subclinical xenobiotic injury, and that exposure limits for lysosomotropic pollutants should account for cumulative, sublethal membrane stress rather than acute cytotoxicity alone. Viewing lysosomal membrane dynamics not merely as a consequence of toxicity, but as an active driver of cell fate, cements this organelle as a pivotal node connecting environmental exposure to human disease outcomes, with translational relevance extending from toxicology and risk assessment to, more narrowly, precision oncology.